Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Colistimethate toxicity. Report of a fatal case in a previously healthy child.

Literature DB >> 5818387

Colistimethate toxicity. Report of a fatal case in a previously healthy child.

K J Ryan, L I Schainuck, R O Hickman, G E Striker.

Abstract

Entities: Disease Species

Mesh：

Substances：
Colistin

Year: 1969 PMID： 5818387 DOI： 10.1001/jama.207.11.2099

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors: Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

2. Colistin: the phoenix arises.

Authors: Jm Conly; Bl Johnston
Journal: Can J Infect Dis Med Microbiol Date: 2006-09 Impact factor: 2.471

3. Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea.

Authors: Y S Cho; H Yim; H T Yang; J Hur; W Chun; J H Kim; B C Lee; D K Seo; J M Park; D Kim
Journal: Infection Date: 2011-09-06 Impact factor: 3.553

4. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors: Sofia K Kasiakou; Argyris Michalopoulos; Elpidoforos S Soteriades; George Samonis; George J Sermaides; Matthew E Falagas
Journal: Antimicrob Agents Chemother Date: 2005-08 Impact factor: 5.191

Colistimethate toxicity. Report of a fatal case in a previously healthy child.

1. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

2. Colistin: the phoenix arises.

3. Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea.

4. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Review 5. Infectious diseases: annual review of significant publications.

6. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design.

Review 7. Causes of polymyxin treatment failure and new derivatives to fill the gap.

Review 8. Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Review 9. 'Old' antibiotics for emerging multidrug-resistant bacteria.

Review 10. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.